MedTrace Logo

Remifentanil Dosing Regimes for Anesthesia in Bariatric Surgery: Characteristics of Early Recovery

NCT04690088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2020-12-30

No results posted yet for this study

Summary

Early recovery characteristics are important for patients' safety and operating room turnover. Our aim was to compare fundamental methods for dosing remifentanil during morbid obesity surgeries: a manual infusion and a target-controlled infusion (TCI). Throughout study, patient's recovery time was tracked and compared between the groups.

Conditions

  • Morbid Obesity

Sponsors & Collaborators

  • Lithuanian University of Health Sciences

    lead OTHER

Eligibility

Min Age
28 Years
Max Age
57 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2019-12-01
Completion
2020-02-10

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04690088 on ClinicalTrials.gov